Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment by McArthur, Simon et al.
Citation: McArthur,  Simon, Pienaar, Ilse, Siddiqi,  Sindhu and Gillies,  Glenda (2015) Sex-
specific  disruption  of  murine  midbrain  astrocytic  and  dopaminergic  developmental 
trajectories following antenatal GC treatment. Brain Structure and Function. ISSN 1863-2653 
(In Press) 
Published by: Springer
URL:  http://dx.doi.org/10.1007/s00429-015-1049-0  <http://dx.doi.org/10.1007/s00429-015-
1049-0>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/22502/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright © and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to  third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page. The content must  not  be 
changed in any way. Full items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
ORIGINAL ARTICLE
Sex-specific disruption of murine midbrain astrocytic
and dopaminergic developmental trajectories following
antenatal GC treatment
Simon McArthur1,2 • Ilse S. Pienaar1,3 • Sindhu M. Siddiqi1 • Glenda E. Gillies1
Received: 13 August 2014 / Accepted: 20 April 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract The mammalian midbrain dopaminergic sys-
tems arising in the substantia nigra pars compacta (SNc)
and ventral tegmental area (VTA) are critical for coping
behaviours and are implicated in neuropsychiatric disor-
ders where early life challenges comprise significant risk
factors. Here, we aimed to advance our hypothesis that
glucocorticoids (GCs), recognised key players in neuro-
biological programming, target development within these
systems, with a novel focus on the astrocytic population.
Mice received antenatal GC treatment (AGT) by including
the synthetic GC, dexamethasone, in the mothers’ drinking
water on gestational days 16–19; controls received normal
drinking water. Analyses of regional shapes and volumes
of the adult SNc and VTA demonstrated that AGT induced
long-term, dose-dependent, structural changes that were
accompanied by profound effects on astrocytes (doubling/
tripling of numbers and/or density). Additionally, AGT
induced long-term changes in the population size and dis-
tribution of SNc/VTA dopaminergic neurons, confirming
and extending our previous observations made in rats.
Furthermore, glial/neuronal structural remodelling was
sexually dimorphic and depended on the AGT dose and
sub-region of the SNc/VTA. Investigations within the
neonatal brain revealed that these long-term organisational
effects of AGT depend, at least in part, on targeting peri-
natal processes that determine astrocyte density and pro-
grammed cell death in dopaminergic neurons. Collectively,
our characterisation of enduring, AGT-induced, sex-
specific cytoarchitectural disturbances suggests novel
mechanistic links for the strong association between early
environmental challenge (inappropriate exposure to excess
GCs) and vulnerability to developing aberrant behaviours
in later life, with translational implications for dopamine-
associated disorders (such as schizophrenia, ADHD, aut-
ism, depression), which typically show a sex bias.
Keywords Antenatal GC treatment  Midbrain 
Astrocytes  Dopaminergic neurons  Neurobiological
programming  Sex dimorphisms
Introduction
During late gestation, a natural rise in the bioavailability of
endogenous glucocorticoid (GC) hormones produced by
the foetal/maternal adrenal glands plays a fundamental role
in the development of mammalian tissues and organs, in-
cluding the brain (Fowden et al. 1998; Van den Bergh et al.
2005). This knowledge underpins the clinical practice of
administering synthetic GCs to women at risk of pre-term
delivery, to accelerate foetal lung maturation and infant
survival (Liggins 1994). A single course of antenatal GC
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treatment (AGT) represents an unquestionable break-
through in perinatal medicine, but repeated courses of AGT
when pre-term delivery is delayed (approximately 50 % of
cases) have been associated with significant effects on
brain structure, neurological function and behaviour in
childhood and adolescence (Talge et al. 2007; Finer et al.
2000; French et al. 2004; Baud and Sola 2007; Yeh et al.
2004; Asztalos 2012). However, the precise nature of GC-
induced changes in the neural systems that regulate be-
haviour remains poorly characterised, but clearly has im-
portant implications from a clinical perspective.
In this regard, the midbrain dopaminergic systems have
received particular interest. These pathways are critical
regulators of normal adaptive behaviours, cognitive and
sensorimotor functions (Williams and Goldman-Rakic
1995; Robbins and Everitt 1996; Bjorklund and Dunnett
2007), and several lines of evidence suggest that they are
particularly vulnerable to in utero challenges, including
exposure to inappropriate elevations in GC levels, due either
to exogenous administration or maternal stressors (Pruess-
ner et al. 2004; Weinstock 2008; Vuillermot et al. 2010;
Gatzke-Kopp 2010; McArthur et al. 2007; Virdee et al.
2014). Furthermore, dysfunction of these pathways is seen in
a range of neuropsychological disorders which have a pu-
tative neurodevelopmental component (Ben Amor et al.
2005; Szpir 2006; Khashan et al. 2008; Raikkonen et al.
2008; Bale et al. 2010; Charil et al. 2010). To date, the
dopaminergic neurons themselves have been the main focus
as potential targets of long-term GC programming in the
brain. In contrast, effects on astrocytes, the main glial cell
type of the brain, are unknown, despite our understanding
that they play critical roles in normal brain development,
structure, function and neuropathology (Barres 2008;
Halassa and Haydon 2010; Schwarz and Bilbo 2012).
Therefore, the present study sought to test our novel hy-
pothesis that exposure AGT in late gestation will have en-
during effects on the astrocytic populations of the adult rat
substantia nigra pars compacta (SNc) and ventral tegmental
area (VTA), which are, respectively, the origins of the ni-
grostriatal and mesocorticolimbic dopaminergic pathways.
Furthermore, as substantial evidence shows that GC neuro-
biological programming leads to behavioural and endocrine
effects which may be qualitatively and quantitatively dif-
ferent in males and females (Gabory et al. 2009; Luine et al.
2007; Lupien et al. 2009; Buss et al. 2007; Brummelte et al.
2012; Schwarz and Bilbo 2012; Sandman and Davis 2012;
Reynolds 2013b; Kreider et al. 2005; Virdee et al. 2013,
2014), our experiments were conducted in both sexes.
Previously, we have shown in rats that AGT increased
the cell counts and altered the topographical organisation of
the dopaminergic neurons in the adult SNc and VTA
(McArthur et al. 2005, 2006, 2007). During late gestation
and the neonatal period, naturally occurring cell death via
apoptotic mechanisms plays a key role in regulating adult
numbers of dopaminergic neurons in the SNc (Jackson-
Lewis et al. 2000; Oo et al. 2003; Burke 2004; Vitalis et al.
2005), but the factors regulating this process are unclear.
Therefore, in the present study, we also tested our predic-
tion (McArthur et al. 2007) that interference with devel-
opmental apoptosis in midbrain dopaminergic neurons
represents a mechanism whereby AGT can permanently
influence the adult population size. Mechanistically, it has
been established that the effects of GCs in the immune and
neuroendocrine systems are mediated via the signalling
protein, annexin A1 (ANXA1) (Hannon et al. 2003;
McArthur et al. 2010; John et al. 2008), but its role in the
brain has received little attention (Solito et al. 2008).
Therefore, the present study was performed in mice in order
first, to establish whether our previous findings of AGT
programming of the rat SNc/VTA dopaminergic neurons
(McArthur et al. 2007, 2010) will be recapitulated mice, and
then to use genetically manipulated mice to investigate
whether a potential mechanism for the effects of AGT on
the midbrain dopaminergic neurons involves ANXA1.
Materials and methods
Animals
All procedures were performed under a licence issued by
the United Kingdom Animals Home Office. CBa/ca mice
were used for the majority of experiments, whilst annexin
A1 (ANXA1) null mice (Hannon et al. 2003) and C57BL/6
wild-type mice were also used, where specified. Mice were
bred in-house and housed in the Imperial College facility,
Hammersmith campus. The animals were maintained under
controlled temperature (21–23 C), humidity (63 %) and
lighting (lights on 08.00–20.00 h), with free access to
standard mouse chow and drinking water. Mice were mated
overnight and matings were confirmed by the presence of
vaginal plugs the following morning. The day following
overnight mating was defined as embryonic day (E) 0.
Pregnancy was confirmed approximately 10 days later via
palpation. Pregnant mice were housed 5 per cage until
gestational day (GD) 15, after which they were caged
singly. The day of birth was defined as postnatal day 0
(P0). Offspring were weaned at P21, after which time the
sexes were housed separately (5 animals per cage) and
allowed to grow to adulthood, during which time they re-
ceived only standard husbandry and no further treatment.
Dexamethasone treatment regimes
In accordance with previously published protocols
(McArthur et al. 2005, 2006, 2007), a non-invasive
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method for late gestational administration of AGT was
employed. The method, comprising of adding dexam-
ethasone sodium phosphate (Faulding Pharmaceuticals
Plc., Royal Leamington Spa, UK) to the drinking water
of the pregnant mice, overcomes the potential con-
founding effects of stress associated with handling the
animals and injection of drugs. The pregnant mice re-
ceiving AGT were divided into two groups, with one
receiving a lower dose of dexamethasone (AGTL, 0.5 lg/
ml in the drinking water) from GDs 16–19, and the other
receiving the higher dose (AGTH, 1.0 lg/ml in the
drinking water) for the same period of time. Dams in the
control group received normal drinking water. There
were no group differences in the volumes of water con-
sumed, which were 15.54 ± 0.45, 12.00 ± 1.46 and
13.09 ± 1.5 ml (mean ± standard error of mean, SEM)
for controls, AGTL, and AGTH, respectively, representing
a daily dose of approximately 150–175 lg/kg (AGTL) or
300–350 lg/kg (AGTH). As discussed previously
(McArthur et al. 2006, 2007), the levels of endogenous
GCs that are required for normal lung maturation during
late gestation are in the range of physiological ‘stress’
levels and, from a pharmacokinetic standpoint, the opti-
mal dose of dexamethasone for mimicking this in rats
has been estimated to be 288 lg/kg/day over GD 18–20
(Samtani et al. 2006a, b). Although equivalent pharma-
cokinetic data are not available for the mouse, the chosen
dose of AGTL and AGTH span a relevant range and,
moreover, are in the range used in clinical perinatal
medicine (Jobe and Soll 2004; Yeh et al. 2004). This
treatment had no significant effect on maternal behaviour
or the offspring’s adult body weight (McArthur et al.
2007). When analysing the effects of AGT on the adult
SNc and VTA, the potential effects of litter of origin
were minimised using one male/female per litter per
treatment group (n = 6 per group).
Tissue collection and processing
Adult brains
At P67 ± 2, mice underwent terminal anaesthesia via in-
traperitoneal injection of 100 ll sodium pentobarbitone.
This was followed by transcardial perfusion using 0.9 %
heparinized saline (until the fluid exiting the cut right atrium
was entirely clear), followed by 20–30 ml of 4 %
paraformaldehyde dissolved in 0.1 M phosphate-buffered
saline (PBS, 0.1 M NaH2–PO42H2O, 0.1 M Na2HPO4-
12H2O, 0.15 M NaCl, all reagents purchased from VWR
International, Poole, UK). Brains were rapidly removed
from the skull and post-fixed in 4 % paraformaldehyde
(PFA) for*23 h, then cryoprotected by immersion in 30 %
sucrose for *72 h, before freezing them on dry ice and
storing them at -80 C until sectioning. A 1 in 4 series of
coronal sections (20 lm) were cut using a cryostat
(-22 C, Bright Instruments Ltd., Huntingdon, UK) and the
free-floating sections stored (-20 C) in antifreeze solution
(0.1 M NaH2PO4H2O, 0.05 M Na2HPO4, 0.15 Mm NaCl,
50 % v/v ethanediol, 1 % w/v polyvinylpyrrolidone, 0.1 %
w/v NaN3, VWR International).
P2 brains
To investigate for developmental apoptosis in dopaminer-
gic neurons, a separate set of coronal mouse brain sections
were collected from mice euthanised at P2, with tissue
preparation adapted for the immature brains. Briefly, mice
were decapitated, brains removed, fixed in 4 % PFA for
4 days, cryoprotected in 30 % sucrose for 2 days, frozen
on dry ice and stored (-80 C). Cryostat sections (20 lm)
were cut directly onto poly-D-lysine coated glass slides
(-22 C) and stored at -80 C.
Double-antigen immunofluorescence
Adult brains
Double-antigen immunostaining for the dopaminergic
neuronal marker, tyrosine hydroxylase (TH) and the as-
trocyte marker, glutamine synthetase (GS) (Vardimon et al.
1999; Halassa and Haydon 2010) was performed on free-
floating sections. In brief, after rinsing sections with PBS,
they were incubated for 1 h at room temperature (RT) in
10 % normal goat serum (NGS, Serotec, Oxford, UK) to
saturate non-specific binding sites. Sections were then
permeabilized with 0.05 % Triton X-100 (VWR Interna-
tional, UK) in 1 % NGS in PBS for 5 min, followed by
incubation overnight on a shaker at 4 C with a combina-
tion of monoclonal mouse anti-mouse TH (1:4000, Milli-
pore, UK) and polyclonal rabbit anti-mouse GS (1:5000,
Abcam, Cambridge, UK). The following morning, sections
were washed in PBS for 3 9 5 min, before incubation for
1 h at RT in the dark with a mixture of Alexa Fluor 594
dye (red) goat anti-mouse IgG for identifying TH-im-
munoreactive (IR) neurons, and Alexa Fluor 488 dye
(green) goat anti-rabbit IgG (H ? L) both at dilution factor
1:500, Invitrogen, Paisley, UK) for visualising GS-IR cells.
Finally, a 0.5 % solution of Sudan Black B (Sigma, Poole,
UK) in 70 % ethanol was applied to the sections for 5 min.
Since Sudan Black B binds lipofuscin present in neurons,
the treatment reduces autofluorescence (Romijn et al.
1999). Sections were then rinsed and allowed to air dry on
gelatin-coated slides before being mounted with Vectorset
mounting medium (Vector Laboratories, UK) in a rostro-
caudal direction.
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P2 brains
Coronal sections were subjected to immunofluorescent
detection of TH (as described above) followed by nuclear
counterstaining with a 0.03 % solution of fluorescent 40,6-
diamidino-2-phenylindole (DAPI, Vector Laboratories) in
0.01 M PBS for 20 min prior to mounting. These sections
were used for visualisation of chromatin condensation and
nuclear chromatin clumps, which are characteristic of
apoptosis (Oo and Burke 1997; Oo et al. 2003). Apoptotic
cell death in dopaminergic neurons was further confirmed
using double-antigen immunofluorescence for TH in ad-
dition to detection of activated caspase-3 using a poly-
clonal rabbit antibody (1:1000; Cell Signaling Technology
Inc., USA). The secondary antibody used for detection of
activated caspase-3 was Alexa Fluor 488-conjugated goat
anti-rabbit IgG (H ? L) (Invitrogen, Paisley, UK; both
1:500), with the sections left to incubate for 1 h at RT. The
sections were washed well in PBS, and then processed for
nuclear counterstaining with DAPI, as described above. All
sections were allowed to air dry on gelatin-coated slides,
and then mounted with Vectorset mounting medium
(Vector Laboratories, UK) in a rostrocaudal direction.
Regional volumes, cell counts and neuronal size
in adult brains
Immunoreactive cells were visualised at 159 magnification
using a Nikon TE2000U epifluorescence microscope fitted
with red and green band-pass filters, a Plan Achromat 109
objective lens, and a 1.59 magnifying lens, linked to a
Hamamatsu C4742-95 CCD camera (Hamamatsu Photon-
ics UK, Welwyn Garden City, UK) and an Apple Macin-
tosh G5 computer, running Openlab 5.5 software (Perkin-
Elmer, Coventry, UK). Images were coded and stored in a
way such that the person performing the cell analysis was
unaware of the treatment groups. Each section was pro-
jected onto a computer monitor and the contours of the SNc
and VTA were delineated by the TH-IR neuronal groups
and by referring to visual anatomical landmarks and to the
mouse brain atlas of Franklin and Paxinos (Franklin and
Paxinos 2008). The SNc can be clearly distinguished from
the surrounding non-DA regions of the thalamus dorsally,
and the substantia nigra pars reticulata (SNr) ventrally by
the presence of TH-IR cells, and from the adjacent VTA by
the third cranial nerve tract that runs between the two nu-
clei. The VTA was delineated by the TH immunopositive
region bordered medially by the interfascicular nucleus and
the interpeduncular nucleus, and dorsally by the para-
brachial-pigmented nucleus. Where the SNr was analysed
as a control region, it was defined as the region of tissue
ventral to the SNc and dorsal to the glia limitans on the
ventral surface of the brain. To detect any regional
differences in volume/shape and cell distribution through
the SNc/VTA, sections containing the nuclei were divided
into four levels (A–D), each spanning 200–250 lm, in a
manner analogous to that which we have used previously
for analysing the rat SNc/VTA (McArthur et al. 2007),
beginning at the anatomical level represented at around
-2.7 mm relative to bregma, where the SNc TH-IR cells
first appear. Representative images at each level are shown
in Fig. 1. Level A was defined solely as the SNc, due to
difficulties in distinguishing the very rostral parts of the
VTA, which begin to mix with the SNc at this level; level
D was defined as the most caudal level for analysis to avoid
the problem of distinguishing the dopaminergic popula-
tions of the retrorubral field, which mix with the caudal
SNc (Fu et al. 2012). Using this delineation, the majority of
the TH-IR cells bodies, which are used to define the con-
tours of the nuclei within which the astrocytes (GS-IR
cells) are counted, are included in the 4 levels of our
analysis, and the TH-IR at levels more caudal to level D is
largely due to cell fibres, rather than perikarya, that slowly
coalesce to form the MFB.
Regional volumes were calculated using Cavalieri’s
method (McArthur et al. 2007) where the cross-sectional
area for each level (A–D) of the SNc/VTA, defined by the
presence of TH-IR cells, was measured, multiplied by 20
(the section thickness before staining of sections cut at
20 lm) and then quadrupled (to account for staining every
4th section); the overall volume was the sum of the volumes
for levels A–D (SNc) and B–D (VTA). The process of fixing,
staining andmounting results in a degree of tissue shrinkage,
but as this value is constant across all treatment groups, it
was not accounted for in the analysis (McArthur et al. 2007).
To estimate the total cell population per level per ani-
mal, IR cells within the whole region of interest were
counted manually using the count function plug-in avail-
able in ImageJ (Rasband, US National Institutes of Health,
version 1.4., http://rsb.info.nih.gov/ij/). This two-dimen-
sional counting technique is most appropriate for relatively
small nuclei such as the SNc and VTA because it allows for
the inclusion of all cells across the whole of the coronal
plane, providing a large sampling window for accurate
assessment (McArthur et al. 2007; Virdee et al. 2014). It
has also been demonstrated that such empirically derived
counts of dopaminergic neurons in the SNc, using serial
reconstruction, are not significantly different from those
obtained using stereological methods (Baquet et al. 2009).
To estimate TH-IR cell size, six such cells per level per
animal were randomly chosen from digital images of coded
sections, selecting only cells in which the nucleus could be
readily identified. From such images, the cross-sectional
area was calculated (McArthur et al. 2007). The mean cell
areas per level per animal were pooled to form the group
means (n = 6).
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Morphological analysis of immature brains
A z-stack of optical sections was captured from each
mouse brain tissue slice that had been counterstained with
DAPI, using a Leica TCS SP5 inverted confocal laser
scanning imaging system (Leica Microsystems, Heidel-
berg, Germany) equipped with a Leica DFC 320 digital
camera, and powered by a Chameleon Ultra-II MP laser
(Coherent Inc., CA, USA) and visualised with red–green–
blue RGB lasers (Leica Microsystems). The confocal z-s-
tacks were taken in 0.78 lm steps with an apochromat
639/1.4 NA oil-immersion objective lens, in sequential
scanning mode. All parameters (pinhole, contrast, gain and
offset) were held constant for all sections from the same
experiment. The captured images were saved with North-
ern Eclipse software (Empix Imaging Inc., Mississauga,
Canada), exported as TIFF files, and processed post-cap-
ture using Adobe Photoshop software (version 7.0), ad-
justing them for levels of brightness and contrast. Images
were merged automatically using the built-in functions
available in Photoshop software.
We found that the accuracy of delineating the SNc and
VTA at P2 was relatively poor, so the region was measured
as a single entity. Apoptotic profiles were quantified by
scanning the entire SNc/VTA for each section. TH-IR
neurons were classified as apoptotic when their DAPI-s-
tained nuclei appeared condensed, round, brighter and/or
fragmented, compared to healthy nuclei (Ahmadi et al.
2003). Moreover, apoptotic nuclei were identified by de-
tection of nuclear chromogen condensation, a morpho-
logical alteration indicative of apoptosis (Oo and Burke
1997; Blomgren et al. 2007). Other studies have confirmed
that apoptotic profiles assessed using similar methods
represent unbiased counts appropriate for the quantification
of natural cell death in dopaminergic neurons (Oo and
Burke 1997; Oo et al. 2003; Jackson-Lewis et al. 2000).
Images were analysed post-capture using ImageJ software.
Nuclear profiles surrounded by TH-IR cytoplasm were
counted in 5 tissue sections per animal, and the proportion
of cells exhibiting chromatin condensation was calculated.
Group means were calculated from these values.
Confirmation of apoptotic cell death was made by co-lo-
calisation of activated caspase-3 IR within TH-IR cells.
Statistical analysis
Statistical analyses were carried out using SigmaPlot sci-
entific data analysis and graphing software package (v.
12.5, Systat Software Inc, London, UK). Preliminary ana-
lysis assessed whether data were normally distributed, by
performing a Kolmogorov–Smirnov test. Global analysis
of variances (ANOVAs) were initially performed on data
groupings for each parameter measured, these being cell
number and nucleus volume with sex, AGT regimen and
level of the SNc/VTA comprising as factors. Data were
then subdivided according to the interacting factors, and
lower order effects of sex and AGT treatment were ex-
amined by means of a one-way ANOVA test, followed by
post hoc analysis by means of a Tukey’s honestly sig-
nificant difference (HSD) test. A probability value of
p\ 0.05 was considered significant.
Results
Global three-way ANOVA revealed significant three-way
interactions between sex, level and treatment for the pa-
rameters described below, as presented in Online Resource 1.
AGT effects on regional volumes in the adult SNc
and VTA
The overall shape of the SNc was similar in control male
and female mice, but the sum of the volumes at each level
was significantly greater in females compared with males
by 31 %, with the major difference occurring at level A
(Fig. 2a, b, open bars). AGTL had no effect in either sex
(Fig. 2a, b, grey bars). In males, AGTH induced a marked
overall change in the shape of the nucleus, as seen by an
increase in volumes at levels C and D, resulting in a net
increase (28 %) in overall volume (Fig. 2a, black bars). In
contrast, in females, AGTH decreased overall SNc volume
Fig. 1 Representative images, moving in a rostrocaudal direction, at the different levels of the SNc (a–d) and VTA (b–d)
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by 17 % due to a substantial effect only at level A (Fig. 1b,
black bars).
The overall VTA volume was similar in control male
and female mice although a significantly greater volume
at level D in females indicates a sex difference in the
overall shape (Fig. 2c, d open bars). As for the SNc,
AGTL had no effect in either sex, whereas AGTH in-
creased total volume in males by 64 % due to significant
effects at C and D, resulting in a marked change in the
overall shape of the nucleus (Fig. 2c, black bars). How-
ever, in females there was no overall effect of AGTH
(Fig. 2d, black bars).
AGT effects on astrocytes in the adult SNc and VTA
The GS-IR cell count and distribution within the SNc were
similar in control males and females (Fig. 3a, b, open bars).
In both sexes, AGTL resulted in a two- to threefold increase
in the estimated total GS-IR cell count, as well as the
counts at individual levels (Fig. 3a, b, grey bars). Females
were affected to a greater extent than males, leading to a
significant sex difference. This effect was sustained in
males after AGTH, but in females AGTH had no significant
effect (Fig. 3a, b, black bars).
The estimated total GS-IR cell counts made within the
VTA were also similar in control males and females,
although a notably lower count at level B in females would
indicate a significant sex difference in the distribution of
astrocytes throughout the VTA (Fig. 3c, d, open bars). In
both sexes, AGTL induced a remarkable three- to fourfold
increase in the estimated total adult GS-IR cell numbers,
due to a particularly marked effect at level B in males and
at both levels B and D in females (Fig. 3c, d, grey bars).
There was thus a sex difference in regional responsiveness
of the astrocytes, which led to the estimated total GS-IR
cell count in the adult female VTA being double that seen
in the male after exposure to AGTL. AGTH also greatly
increased in the estimated total GS-IR cell numbers in
males, and, in contrast to AGTL, significant effects were
seen at all 3 levels, indicating dose effects on regional
Fig. 2 The volume of individual levels A–D and total volume for the
SNc (a, b) and VTA (c, d) of male (a, c) and female (b, d) mice in
adulthood following antenatal treatment with dexamethasone via the
maternal drinking water on embryonic days 16–19 (grey bars lower
dose antenatal GC treatment, AGTL, 0.5 lg/ml; black bars higher
dose antenatal GC treatment, AGTH, 1.0 lg/ml) compared to the
control offspring of dams receiving normal drinking water (open
bars). Data are mean ± SEM, n = 6 animals per treatment group. Up
filled triangle, down filled triangle dexamethasone treatment had a
significant effect, p\ 0.05, to increase or decrease volume, respec-
tively, compared with control animals; plus a significant sex
difference, p\ 0.05 vs. males in the same treatment group
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responsiveness. In females, however, AGTH was without
effect. This sexually dimorphic pattern of responses in the
VTA mirrored that seen in the SNc.
To evaluate the relationship between regional volumes
(Fig. 2) and astrocyte numbers (Fig. 3), GS-IR cell density
is presented in Table 1. This reveals that exposure to AGTL
caused a two- to threefold increase in astrocyte density at
all levels of the SNc and VTA in both sexes, except for the
VTA at level C in females, where an almost sevenfold
increase led to a significant sex difference. In contrast,
AGTH failed to alter GS-IR cell density in any region or
sex, except for the female VTA at level C, where the in-
crease in density (threefold) was approximately half that
seen with the lower dose of AGT. Notably, neither AGTL
nor AGTH affected adult GS-IR cell density in the neigh-
bouring SNr in either sex (Table 1), indicating that the
effect in the SNc and VTA was not a uniform, non-specific
effect throughout the brain.
AGT effects on TH-IR cells in the adult SNc
and VTA
TH-IR cell counts within the adult SNc were similar in
control males and females (Fig. 4a, b open bars). AGTL
had no overall effect in male mice, but significantly in-
creased the estimated total cell count in females due to a
predominant effect at level A. In contrast, AGTH increased
counts at C and D in male mice, leading to an overall
significant increase (32 %) in the estimated total TH-IR
cell count, whereas females were unaffected by AGTH.
In the VTA, TH-IR cell counts were similar in control
males and females, but at the individual levels C and D
counts were significantly lower or higher, respectively, in
females compared with males, indicating a sex difference
in the distribution of dopaminergic neurons throughout the
nucleus (Fig. 4c, d). In males AGTL significantly increased
counts at level B and decreased them at C, with no net
Fig. 3 GS-IR cell counts at the individual levels A–D and total cell
counts over the entire SNc (a, b) and VTA (c, d) of male (a, c) and
female (b, d) mice in adulthood following antenatal treatment with
dexamethasone via the maternal drinking water on embryonic days
16–19 (grey bars lower dose antenatal GC treatment, AGTL, 0.5 lg/
ml; black bars higher dose antenatal GC treatment, AGTH, 1.0 lg/ml)
compared to the control offspring of dams receiving normal drinking
water (open bars). Data are mean ± SEM, n = 6 animals per
treatment group. Up filled triangle, down filled triangle dexametha-
sone treatment had a significant effect, p\ 0.05, to increase or
decrease cell counts, respectively, compared with control animals;
plus a significant sex difference, p\ 0.05 vs. males in the same
treatment group
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overall effect, whereas AGTH increased estimated total
counts by 62 % due to effects at C and D. Females, in
contrast, responded only to AGTL with significantly in-
creased counts at B and C.
Table 2 shows that, with only one exception, neither
dose of AGT affected regional TH-IR cell density in the
adult SNc and VTA of either sex. The one exception was
the female VTA at level C, where TH-IR cell density was
increased approximately fourfold or threefold after AGTL
or AGTH, respectively. There are thus sex effects on re-
gional responsiveness.
Measurement of cross-sectional areas of TH-IR cell
bodies established that there were regional or sex differ-
ences, with the average respective values (mean ± s.e.m,
lm2) for males and females being 113.5 ± 2.6 and
112.1 ± 2.3 for the SNc and 125.3 ± 7.3 and 114 ± 2.9
for the VTA. No significant interactions of treatment
groups were seen. Thus, regional changes in volume or cell
density cannot be attributable to any effects of AGT on
TH-IR cell sizes.
AGT influences at P2
As a peak of programmed cell death (PCD) via apoptosis
has been reported at P2 (Burke 2004), the effects of AGTL
on apoptotic markers in TH-IR were assessed at this time
point. Figure 5a provides an example of chromogen con-
densation (blue DAPI fluorescence) in the nucleus of a TH-
IR neuron (red fluorescence), which is also co-localised
with active caspase-3 (green fluorescence), as confirmed by
the merged image. At a lower magnification, Fig. 5b il-
lustrates that the cells exhibiting nuclear chromatin con-
densation are also positive for TH-IR, and all analyses
indicated that apoptotic markers were restricted to TH-IR
cells, with no evidence of apoptosis in glial cells. In both
wild-type and ANXA1-null mice, AGTL markedly sup-
pressed apoptosis in the male and female SNc/VTA, indi-
cating no role for ANXA1 in programmed cell death of the
midbrain dopaminergic neurons (Fig. 5c, d). At P2, the
density of GS-IR cells was significantly increased in both
sexes by AGTL in the SNc/VTA region (Fig. 6a), in the
SNr (Fig. 6b) and also in the red nucleus (data not shown).
A qualitative summary of the main effects of the two
doses of AGT on the estimated numbers and density of
astrocytes and dopaminergic neurons in the SNc and VTA
of adult male and female rats, as well as neonatal apoptosis
in these regions is provided in Table 3.
Discussion
Although GCs are widely accepted as potent mediators of
neurobiological programming in the brain (Seckl and
Holmes 2007; Reynolds 2013a), little is known of their
impact on astrocytic populations. The present study has
identified dose-dependent effects of AGT on the structure
and volume of the mouse SNc and VTA that are associated
with marked effects on the number, density and distribution
of astrocytes, as well as neurons, in these regions. More-
over, these effects were sexually dimorphic, depending on
the dose of AGT as well as the sub-region of the SNc/VTA,
and were super-imposed on intrinsic sex differences in
volume, shape and/or distribution of astrocytes and
dopaminergic neurons in control animals. These findings
thus provide new data highlighting astrocytes as AGT
targets that contribute to the structural remodelling of the
SNc and VTA as a result of inappropriate exposure to GCs
in late gestation. They also add new data in support of the
mounting evidence that the impact of early life challenges
within the brain is sexually dimorphic (Gabory et al. 2009;
Luine et al. 2007; Lupien et al. 2009; Buss et al. 2007;
Table 1 Influence of AGT on GS-IR cell density in the adult brain
GS-IR cell density (9104 cells/mm3)
Level Control AGTL AGTH
SNc
Male A 0.27 ± 0.01 0.65 ± 0.08* 0.55 ± 0.07
B 0.42 ± 0.09 1.06 ± 0.31* 0.55 ± 0.02
C 0.28 ± 0.04 1.10 ± 0.05* 0.38 ± 0.09
D 0.39 ± 0.05 0.78 ± 0.17* 0.44 ± 0.07
Female A 0.34 ± 0.04 0.69 ± 0.07* 0.44 ± 0.10
B 0.54 ± 0.11 0.95 ± 0.15* 0.38 ± 0.09
C 0.26 ± 0.02 0.62 ± 0.16* 0.27 ± 0.03
D 0.28 ± 0.02 0.97 ± 0.25* 0.33 ± 0.13
VTA
Male B 0.23 ± 0.02 0.72 ± 0.10* 0.44 ± 0.03
C 0.36 ± 0.07 1.12 ± 0.11* 0.51 ± 0.09
D 0.23 ± 0.02 0.69 ± 0.11* 0.32 ± 0.03
Female B 0.22 ± 0.02 0.76 ± 0.10* 0.24 ± 0.04
C 0.09 ± 0.01? 0.61 ± 0.23*,? 0.31 ± 0.06?
D 0.28 ± 0.06 0.85 ± 0.11* 0.27 ± 0.04
SNr
Male – 1.66 ± 0.23 2.01 ± 0.33 1.84 ± 0.12
Female – 2.08 ± 0.19 2.20 ± 0.20 1.75 ± 0.37
Density of GS-IR cells throughout the SNc, VTA and SNr of male
and female mice in adulthood following treatment with dexametha-
sone via the maternal drinking water prenatally on embryonic days
16–19 (AGTL 0.5 lg/ml; AGTH 1.0 lg/ml) compared to the control
offspring of dams receiving normal drinking water. Data are
mean ± SEM, n = 6 animals per treatment group
* Significant effect of treatment, p\ 0.05 for dexamethasone-treated
vs. control animals
? Significant sex difference, p\ 0.05 vs. males in the same treat-
ment group
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Brummelte et al. 2012; Schwarz and Bilbo 2012; Sandman
and Davis 2012; Reynolds 2013b; Kreider et al. 2005;
Virdee et al. 2013, 2014). Additionally, the data demon-
strate for the first time that AGT-dependent programming
of dopaminergic cell numbers occurs in mice and follows a
similar pattern to that which we have reported previously in
rats (McArthur et al. 2007; Virdee et al. 2014). This
comparison identifies AGT-induced neurobiological pro-
gramming with the midbrain dopaminergic systems as a
robust, interspecies phenomenon, thereby laying the basis
for future work in transgenic animals to better understand
the mechanisms underlying environmental/epigenetic pro-
gramming of key pathways controlling adaptive behaviours
and their likely susceptibility to malfunction.
Regional volumes and shape in the adult SNc/VTA
The present study revealed an intrinsic sex difference in the
overall volume (SNc) and shape (SNc and VTA) of the
midbrain nuclei in control animals. As sex differences in
regional brain volumes strongly associate with behavioural
differences in humans and rodents (Cahill 2006; Cosgrove
et al. 2007; Swaab 2008; Forger 2009), these findings
provide structural evidence in support of functional sex
differences (behavioural, neurochemical and neurodegen-
erative responses) that have been reported for these regions
in the normal brain (Gillies et al. 2014a, b; Becker and Hu
2008). The effects of AGT on regional volume appeared to
be dose-dependent, with only the group exposed to the
higher dose showing neuroanatomical disturbances. Nota-
bly, however, the effect in males was to increase the overall
SNc and VTA volumes (effects at caudal levels C, D),
whereas in females overall volume fell in the SNc (changes
rostrally at level A), with no effects in the VTA, thereby
exaggerating the sex dimorphisms seen in control animals.
To date, structural changes induced by early life GC ex-
posure have been reported for the hippocampus, amygdala,
prefrontal cortex and hypothalamus, with evidence for
different effects in males and females as well as for links to
neuropsychiatric disorders (Uno et al. 1994; Vythilingam
Fig. 4 TH-IR cell counts at the individual levels A–D and total cell
counts over the entire SNc (a, b) and VTA (c, d) of male (a, c) and
female (b, d) mice in adulthood following antenatal treatment with
dexamethasone via the maternal drinking water on embryonic days
16–19 (grey bars lower dose antenatal GC treatment, AGTL, 0.5 lg/
ml; black bars higher dose antenatal GC treatment, AGTH, 1.0 lg/ml)
compared to the control offspring of dams receiving normal drinking
water (open bars). Data are mean ± SEM, n = 6 animals per
treatment group. Up filled triangle, down filled triangle dexametha-
sone treatment had a significant effect, p\ 0.05, to increase or
decrease cell counts, respectively, compared with control animals;
plus a significant sex difference, p\ 0.05 vs. males in the same
treatment group
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et al. 2002; Gilbertson et al. 2002; Sapolsky 2002; Coe
et al. 2003; Geuze et al. 2005; Buss et al. 2007, 2012;
Lupien et al. 2009; Rao et al. 2010; McEwen and Gianaros
2010; Charil et al. 2010; Garcia-Caceres et al. 2010). The
present study therefore highlights the potential for SNc/
VTA volume changes to be used as a sensitive, non-inva-
sive biomarker for disorders where early life environmental
challenges, as well as dopaminergic malfunction, con-
tribute to their aetiologies.
Astrocytes
Adult SNc/VTA
To our knowledge, this is the first study to demonstrate that
brief prenatal exposure to GCs has dramatic, enduring
consequences for the number and density of astrocytes in
the adult brain. In both sexes, AGTL increased SNc/VTA
astrocyte counts. However, contrary to expectations, this
did not affect the volume of these regions. This
demonstrates that cellular changes can occur without overt
structural changes and highlight the importance of coupling
functional/biochemical markers with volumetric measure-
ments (discussed above) as potential aids to diagnosis or the
understanding of the aetiology of brain disease (Pruessner
et al. 2004). Astrocyte counts were similarly increased in
the male group treated with the higher dose of AGT, but,
unlike the lower dose, regional volumes also expanded such
that astrocyte density was largely unaffected. Whether as-
trocyte size accounts for these differences remains to be
determined. Factors that regulate astrocyte size are largely
unknown, but this is critical to their function as each oc-
cupies a large, unique spatial domain, associating with
several hundred dendrites and 100,000 synapses in the ro-
dent brain, and 20-fold more synapses in the human brain
(Freeman 2010). Although GS-IR is very effective for vi-
sualising the immediate astrocyte cell body for cell count-
ing purposes, it provides little information on astrocyte size.
The alternative use of glial fibrillary acidic protein (GFAP),
a cytoskeletal protein, as an astrocytic marker would offer
no further advantages because it reveals approximately only
15 % of total astrocytic volume (Freeman 2010; Halassa
and Haydon 2010). Further studies are therefore needed to
discover the precise contributions of astrocytes to AGT-
induced structural changes.
In contrast to findings in males, astrocytes of the female
SNc/VTA were largely unresponsive to AGTH. Together,
these sexually dimorphic AGT-induced alterations in the
astrocytic environment, which would inevitably impact on
midbrain dopaminergic function, suggest a novel mechan-
ism which may underpin the sex-specific effects of early
environmental disturbances on adult behaviours. In support
of this, astrocyte disruptions are increasingly being recog-
nised in DA-dependent CNS pathologies, which exhibit sex
differences as well as a developmental component, in-
cluding schizophrenia, depression and neurodegenerative
disorders (Barres 2008; Halassa and Haydon 2010; Rappold
and Tieu 2010).
Neonatal SNc/VTA
The effect of AGTL to increase GS-IR cell density was
manifested by P2. As most astrocytes are produced post-
natally (Bandeira et al. 2009), and cessation of AGT at E19
ensures that the mice are dexamethasone-free by P21, these
results establish that postnatal astrocyte development is
highly sensitive to prenatal events, the course of which can
be altered by AGT. In the developing vertebrate CNS
neural precursor cells first generate neurons and then un-
dergo a ‘‘neurogenic-to-gliogenic switch’’ late in gestation
in rodents (Freeman 2010), but the triggers of this switch
are unknown. However, the GC receptor (GR) is widely
expressed in astrocytes, GCs can up-regulate GS
Table 2 Influence of AGT on TH-IR cell density in the adult brain
TH-IR cell density (9104 cells/mm3)
Level Control AGTL AGTH
SNc
Male A 2.76 ± 0.12 3.07 ± 0.2 3.11 ± 0.27
B 3.36 ± 0.87 2.86 ± 0.23 3.23 ± 0.74
C 3.19 ± 0.53 2.23 ± 0.13 2.77 ± 0.47
D 3.27 ± 0.7 2.46 ± 0.22 2.87 ± 0.16
Female A 2.71 ± 0.32 3.42 ± 0.26 2.87 ± 0.09
B 3.47 ± 1.21 3.00 ± 0.25 2.55 ± 0.26
C 2.60 ± 0.27 2.72 ± 0.32 2.70 ± 0.18
D 2.93 ± 0.39 2.49 ± 0.24 2.69 ± 0.12
VTA
Male B 2.92 ± 0.41 3.75 ± 0.45 3.15 ± 0.40
C 3.98 ± 0.12 3.61 ± 0.36 3.46 ± 0.33
D 3.31 ± 0.27 2.97 ± 0.30 3.09 ± 0.52
Female B 3.20 ± 0.28 3.97 ± 0.43 2.72 ± 0.35
C 1.05 ± 0.12? 4.72 ± 0.09* 3.58 ± 0.59*
D 3.50 ± 0.32 3.83 ± 0.17 3.60 ± 0.21
Density of TH-IR cells at each level throughout the substantia nigra
pars compacta (SNc) and ventral tegmental area (VTA) of male and
female mice in adulthood following treatment with dexamethasone
via the maternal drinking water prenatally on embryonic days 16–19
(AGTL 0.5 lg/ml; AGTH 1.0 lg/ml) compared to the control off-
spring of dams receiving normal drinking water. Data are mean ±
SEM, n = 6 animals per treatment group
* Significant effect of treatment, p\ 0.05 for dexamethasone-treated
vs. control animals
? Significant sex difference, p\ 0.05 vs. males in the same treat-
ment group
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expression, and maturation of the adrenal gland has been
linked to glial differentiation, at least in the chick retina
(Vardimon et al. 1999; Zschocke et al. 2005). Our results in
mice therefore add to and extend the evidence that GCs are
important for astrocyte ontogeny and suggest the intriguing
hypothesis that they have a role in regulating neural pre-
cursor cell fate.
AGTL influences on astrocyte density in the SNc/VTA
were qualitatively similar in both sexes at P2 and in
adulthood, but quantitatively values fell five- to tenfold
between these periods. A contrasting pattern was seen in
the SNr, where both inherent sex differences and a positive
effect of AGT on astrocyte density at P2 were absent in
adulthood, and developmental changes in density were
relatively small (*30 %). The mechanisms underlying
these changes require further investigation, but the current
data suggest that important processes in midbrain devel-
opment intervene between the neonatal period and adult-
hood, and are region- and sex-specific. Together, our novel
findings in the adult and neonatal SNc/VTA clearly high-
light the need for a better understanding of neuronal–glial
interactions in the midbrain dopaminergic systems, as well
astrocyte vulnerability to hormonal disruption, which re-
main relatively under-investigated.
Fig. 5 A proportion of murine TH-IR cells undergo apoptotic
changes on postnatal day P2, as identified by immunostaining for
activated caspase-3 (a), or by the presence of nuclear condensation
(b), white arrow an example of pronounced nuclear condensation.
TH-IR cell apoptosis was quantified in the combined SNc and VTA at
postnatal day P2 in male and female wild-type (c) or annexin A1 null
(d) mice treated with dexamethasone via the maternal drinking water
antenatally on embryonic days 16–19 (grey bars 0.5 lg/ml), and
compared to the control offspring of dams receiving normal drinking
water (open bars). Data are mean ± SEM, n = 6 animals per
treatment group. Asterisk a significant effect of treatment, p\ 0.05
for dexamethasone-treated vs. control animals
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Dopaminergic neurons
Adult SNc/VTA
The present work demonstrated that AGT permanently
increased TH-IR neuron numbers in the mouse SNc and
VTA in both sexes, although sex dimorphisms in regional
responsiveness and dose effects occurred, resulting in no-
table sex differences in the number and distribution of
dopaminergic neurons after AGT. These results reca-
pitulate our previous findings in the rat of an AGT-induced
increase in the population size and topographical re-or-
ganisation of the midbrain dopaminergic neurons (McAr-
thur et al. 2005, 2007), with implications for their
connectivity and function (Brodski et al. 2003; Bjorklund
and Dunnett 2007; Roeper 2013). We have also demon-
strated that other neurobiological indicators of dopamin-
ergic transmission, such as striatal levels of the DA
Fig. 6 Density of GS-IR cells in the combined SNc and VTA (a) and
adjacent SNr (b) of male and female mice at postnatal day P2
following treatment with dexamethasone via the maternal drinking
water antenatally on embryonic days 16–19 (grey bars 0.5 lg/ml)
compared to the control offspring of dams receiving normal drinking
water (open bars). Data are mean ± SEM, n = 6 animals per
treatment group. Asterisk a significant effect of treatment, p\ 0.05
for dexamethasone-treated vs. control animals. Plus a sex difference,
p\ 0.05
Table 3 Summary of principal
findings
SNc VTA
Males Females Males Females
AGTL AGTH AGTL AGTH AGTL AGTH AGTL AGTH
Volume = :
C, D
= ;
A
= :
C, D
= =
GS-IR cell counts ::
A–C
::
A, C, D
::
A–D
= ::
B, C
::
B, C, D
::
B, D
=
GS-IR cell density ::
A–D
:
A
::
A–D
:
A
::
A–D
:
B
::
A–D
:
C
TH-IR cell counts = :
C, D
:
A
= = :
C, D
:
B, C
=
TH-IR cell density = = = = = = = ::
C
Apoptosis ; NA ; NA ; NA ; NA
The qualitative changes in the adult mouse SNc and VTA consequent on antenatal treatment with dex-
amethasone via the maternal drinking water on embryonic days 16–19 (lower dose antenatal glucocorticoid
treatment, AGTL, 0.5 lg/ml; higher dose antenatal glucocorticoid treatment, AGTH, 1.0 lg/ml) are com-
pared to the control offspring of dams receiving normal drinking water. = denotes no change with treat-
ment; : a significant increase compared with relative control; :: a significant increase by [100 %
compared with relative control; ; a significant decrease compared with relative control; NA this parameter
was not assessed in this treatment group. A, B, C or D indicates the level(s) where a significant effect was
seen
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transporter, the DA Type 1 receptor and amphetamine-s-
timulated DA release, also changed markedly in animals
exposed to AGT, but in a diametrically opposite direction
in males and females, which we have proposed represent
sexually dimorphic adaptive mechanisms (Virdee et al.
2014). Given the importance of astrocytes for normal
functioning of the SNc and VTA systems, the present data
suggest that astrocytic programming by in utero GC ex-
posure may contribute to these sexually dimorphic com-
pensatory processes which underpin behavioural resistance,
susceptibility or instability [allostatic load (McEwen 1998;
Beauchaine et al. 2011)].
It remains to be determined whether the effects of AGT
on GS-IR cells could be related to, or compensate for,
effects on TH-IR cells. The comparative data summary in
Table 3 illustrates that the regional effects of AGT on as-
trocyte numbers in the adult brain do not match concomi-
tant changes in dopaminergic neuron numbers and there is
no concordance between the directional change in astro-
cytic/neuronal numbers and volume in males and females.
The data thus indicate a complex, sex-specific pattern
where the influences of AGT on dopaminergic neurons and
astrocytes may well be independent.
Neonatal SNc/VTA
Neurogenesis, specification and migration of the midbrain
dopaminergic neurons are largely complete in the mid-
brain before commencement of AGT (Smidt and Burbach
2007). Hence, the present study indicates that GCs must
influence already committed neurons during late gesta-
tion. Furthermore, our data on apoptosis within the
dopaminergic neurons at P2 suggest that, mechanistically,
this involves downstream suppression of the wave of
‘classical’ neuronal PCD that occurs just after birth
(Burke 2004). As several important actions of GCs are
mediated via ANXA1 (John et al. 2008; Hannon et al.
2003), and ANXA1 has a putative role in apoptosis by
promoting non-inflammatory phagocytosis of cell debris
derived from various cell types (McKanna 1995; Yona
et al. 2006; McArthur et al. 2010), we reasoned that
ANXA1 could be involved in the mechanism by which
GCs modulate natural cell death in the developing brain.
However, the ability of AGT to suppress expression of
apoptotic makers in wild-type and ANXA1 null mice to a
similar extent argues against ANXA1-dependent
mechanisms in this process, which therefore requires
further investigation.
Although AGTL suppressed apoptosis in the SNc/VTA
to a similar extent in both sexes at P2, this dose increased
the adult TH-IR count only in females. The female data
therefore support the premise that PCD in early life reg-
ulates DA neuron numbers in the adult SNc (Burke 2004).
Longitudinal studies will be required to investigate why a
similar effect did not endure into adulthood in males, but
we propose that intervening developmental processes dif-
ferentially affected by AGT in males and females have
additional influences on the final neuron numbers. In sup-
port of this, amygdala nuclei volumes and numbers of glia
and neurons may be increased or decreased by in utero
programming depending on whether they were assessed
before P25 or after P45, highlighting that outcomes may
differ according to the time of testing (Kraszpulski et al.
2006). The nature of the intervening processes remains
speculative, but emerging evidence implicates adolescence
as a critical window, in addition to the classical neonatal
period, when elevations in gonadal steroid hormones can
organise the brain and programme adult behaviours in
humans and animals (Sisk and Zehr 2005; McArthur et al.
2011; Gillies and McArthur 2010; McCarthy et al. 2008;
Juraska et al. 2013). Together, our findings highlight a need
to understand the impact of sex hormones and their inter-
actions with stress/stress hormones on the ontogeny not
only of the midDA neurons, but also their associated
astrocytes.
Implications and conclusions
As the multi-drug resistance protein, P-glycoprotein, ex-
trudes dexamethasone from the adult brain, access of pe-
ripherally administered dexamethasone to the brain has
been questioned. However, this protein has not been de-
tected in the rodent brain before P7 (Matsuoka et al. 1999).
Additionally, GRs are expressed in the basal ganglia, in-
cluding astrocytes, from E15 in rodents, and GCs can up-
regulate GS expression during development (Vardimon
et al. 1999; Zschocke et al. 2005; Diaz et al. 1998). To-
gether, these observations support the view that AGT may
directly target the cells of the SNc and VTA during
development.
In providing a direct link between GC actions in the
developing brain and cytoarchitectural disturbances in the
adult brain, the current study suggests novel mechanisms
which may underpin the strong association between early
environmental challenges and vulnerability to neuropsy-
chopathologies, such as schizophrenia, attention deficit/
hyperactivity disorder, autism spectrum disorders, sub-
stance abuse, Parkinson’s disease, anxiety and depression
(Ben Amor et al. 2005; Szpir 2006; Khashan et al. 2008;
Raikkonen et al. 2008; Thomas et al. 2009; Hu et al. 2004;
Barlow et al. 2007), which involve the ascending DA
systems and typically show a sex bias (Aleman et al. 2003;
Becker and Hu 2008; Biederman et al. 2002; Baron-Cohen
et al. 2005; Gillies et al. 2014a, b). In support of this, we
have recently demonstrated that specific behaviours that
have psychopathological relevance and are known to
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involve midbrain dopaminergic systems in numerous
species, including rats, mice and humans, are differen-
tially affected by AGT in male and female rats (Virdee
et al. 2014). These relate to female behaviours (moti-
vation, arousal), which are altered in depression [more
prevalent in women (Kessler 2003)] and male behaviours
(pre-attentional processing/pre-pulse inhibition of the
startle response), which are affected in male, but not
female, schizophrenic subjects (Kumari et al. 2008).
Given our evidence for the similarity in AGT program-
ming of the SNc/VTA dopaminergic neurons between
mice and rats, it would seem reasonable to suggest that
cytoarchitectural re-programming would lead to func-
tional consequences in mice, just as it did in rats.
Nonetheless, future studies will be required to ascertain
this, and to consider the alternative hypothesis that as-
trocyte plasticity may represent compensatory mechan-
isms to preserve function, which is a characteristic of the
midbrain dopaminergic systems (Golden et al. 2013;
Virdee et al. 2014).
Although precise information on the differential phar-
macokinetics between humans, rats and mice is lacking,
certain considerations, discussed in detail elsewhere
(McArthur et al. 2006, 2007), support the view that the
doses of dexamethasone selected in the current study hold
physiological and translational relevance. Specifically, they
were in the low clinical range used in perinatal medicine
(Ballard and Ballard 1995; Jobe and Soll 2004) and also
fall within the range required for inducing normal lung
maturation in the rat (Samtani et al. 2006a, b). Further-
more, treatment was administered at a stage in mouse brain
development which approximates to the latter part of the
second trimester of human gestation (Clancy et al. 2001),
when AGT is administered in cases of threatened prema-
ture birth (Liggins 1994). Our findings therefore highlight
the sensitivity of the SNc/VTA neural systems to AGT and
underscore the concerns for incurring neurological deficits
after repeated courses of AGT, which remain in practice,
despite recommendations to the contrary and the lack of
evidence for any proven clinical benefits (Baud and Sola
2007; Seckl and Holmes 2007; Murphy et al. 2008). As GC
programming mechanisms are thought to be similar in
humans and experimental species (Seckl and Holmes
2007), the data also support the validity of our model for
predicting potential neuropathological changes after early
inappropriate exposure to GCs, and for testing strategies to
reverse such effects.
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